DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alnylam Pharmaceuticals, Inc. (ALNY)
« Back to company indexALNY Chatter Timeline
Stock Ticker for ALNY
Most Active Tweeters for ALNY
| User | Tweets |
|---|---|
| @1MinuteStock | 4 |
| @Gambiste1 | 4 |
| @masterlongevity | 3 |
| @portefeuillefun | 3 |
| @AmericanBanking | 3 |
Recent Tweets for ALNY
 |
@masterlongevity @semodough $alny and $ions next gen drugs will have direct comparison to tafamidis. If they beat tafamidis, then… https://t.co/qLvUzqatjZ 5:01pm |
 |
@OTSociety Don't miss this Interview with the 2019 OTS Lifetime Achievement Award Winner Muthiah (Mano) Manoharan! $ALNY… https://t.co/MxMWgjG4oX 12:01pm |
 |
@bbnsnews -$2.21 EPS Expected for Alnylam Pharmaceuticals, Inc. $ALNY This Quarter https://t.co/3FUwOutlCa 4:01am |
 |
@ZolmaxNews Brokerages Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Earnings of -$2.21 Per Share https://t.co/tHpcd6HDd5 4:01am |
 |
@AmericanBanking Brokerages Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Earnings of -$2.21 Per Share https://t.co/PZPNL16d6q #stocks 4:01am |
 |
@TickerReport Alnylam Pharmaceuticals, Inc. Expected to Earn FY2019 Earnings of -$7.94 Per Share $ALNY https://t.co/cUgtQYw5x8 January 17th 2020, 1:01am |
|
@ZolmaxNews Alnylam Pharmaceuticals, Inc. Expected to Earn FY2019 Earnings of -$7.94 Per Share $ALNY https://t.co/HTpL3zYPry January 17th 2020, 1:01am |
 |
@Riggs_Bud Reminder $ALNY picked $A to make API. They signed a 5 year agreement. https://t.co/jwjbMJJIK7 January 16th 2020, 11:01am |
 |
@dailypoliticaln Short Interest in Alnylam Pharmaceuticals, Inc. $ALNY Declines By 10.5% https://t.co/kk0IVP2wuz January 16th 2020, 11:01am |
 |
@ThisLincolnian FY2019 Earnings Forecast for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Svb Leerink https://t.co/rJd5fzLDD3 January 16th 2020, 1:01am |
 |
@EnterpriseLeade FY2019 EPS Estimates for Alnylam Pharmaceuticals, Inc. $ALNY Lifted by Svb Leerink https://t.co/rQAOg6JsPn January 16th 2020, 1:01am |
|
@Riggs_Bud $ALNY JPM Presentation (Leader in RNAi). 2 Approvals with several more in late stages. https://t.co/esddltTw5G https://t.co/AOLyV2NR84 January 15th 2020, 3:01pm |
 |
@shaolintrader88 $ALNY is above desc RL n minor pivot 120.97 January 15th 2020, 11:01am |
 |
@FoxonStocks RT @IBDinvestors: Seeing some alerts on a few biotech stocks this morning... $ALNY $AXSM Technically they have decent set ups but fundament… January 15th 2020, 10:01am |
 |
@WatchlistN Alnylam Pharmaceuticals, Inc. $ALNY Short Interest Update https://t.co/9Kc16vQmye January 15th 2020, 10:01am |
 |
@ConsumerFeed Alnylam Pharmaceuticals, Inc. $ALNY Short Interest Update https://t.co/Mu8SNzlixO January 15th 2020, 10:01am |
 |
@IBDinvestors Seeing some alerts on a few biotech stocks this morning... $ALNY $AXSM Technically they have decent set ups but fun… https://t.co/JZ6eXbw53F January 15th 2020, 9:01am |
|
@AmericanBanking Research Analysts Set Expectations for Alnylam Pharmaceuticals, Inc.’s FY2019 Earnings $ALNY https://t.co/iKpczaVl1s #stocks January 15th 2020, 6:01am |
 |
@DrReddyGI If $ICPT wants to drive adoption, they will probably need to payment model similar to $ALNY does for Givlaari facto… https://t.co/JkcRIxu35l January 14th 2020, 8:01pm |
 |
@SeekingAlpha $ALNY - Alnylam Pharmaceuticals Beats Again, But The Bar Keeps Moving Higher. Keep reading: https://t.co/y51WPM01DD… https://t.co/lMCaR1QT3Y January 14th 2020, 1:01pm |
|
@SeekingAlpha $ALNY - Alnylam Pharmaceuticals (ALNY) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow. Subsc… https://t.co/SfxcfoSASc January 14th 2020, 11:01am |
 |
@Gambiste1 RT @semodough: $ALNY catalyst full data from ILLUMINATE-A trial at OxalEurope International Congress (March 31, 2020); (2) NDA &MAA submiss… January 14th 2020, 7:01am |
 |
@semodough $ALNY catalyst full data from ILLUMINATE-A trial at OxalEurope International Congress (March 31, 2020); (2) NDA &MA… https://t.co/oYIr4Lxqkg January 14th 2020, 6:01am |
 |
@gcassidy718 $ALNY Valuation is starting to make more sense now $103.78. https://t.co/0l22j3EB3u January 14th 2020, 4:01am |
|
@AmericanBanking Short Interest in Alnylam Pharmaceuticals, Inc. $ALNY Decreases By 10.5% https://t.co/zCewPI0GSw #stocks January 14th 2020, 3:01am |
|
@masterlongevity @semodough NOw pretty clear that $alny patisiran will never be a blockbuster . Did $alny provide a 2020 sales forecast? January 13th 2020, 7:01pm |
 |
@MaisaCorp $ALNY Achieved Fourth Quarter and Full Year 2019 ONPATTRO® (patisiran) Preliminary Global Net Product Revenues of A… https://t.co/I6YOvd9nOH January 13th 2020, 4:01pm |
 |
@unc_cmo Finding the middle ground between manufacturer reimbursement and patient access remains a challenge. $ALNY $SNY… https://t.co/ezmj7qcyan January 13th 2020, 2:01pm |
 |
@a_silverstein $ALNY breakout at #JPM20 decidedly smaller than I expected. January 13th 2020, 2:01pm |
 |
@newsfilterio Drugmakers getting creative over ways to pay for pricey meds $ALNY https://t.co/mCXo5YBY5C January 13th 2020, 12:01pm |
|
@Gambiste1 RT @TradeTexasBig: $ALNY is set for a 130s print if this holds monthly pattern January 12th 2020, 10:01pm |
 |
@1MinuteStock Wondering about #sentiment indicator for $ALNY? The Short Ratio is 5.44% https://t.co/9bdopMa3HA January 12th 2020, 10:01pm |
 |
@TradeTexasBig $ALNY is set for a 130s print if this holds monthly pattern January 12th 2020, 9:01pm |
|
@1MinuteStock Btw, Estimated #Earnings Per Share for $ALNY is $-1.36 it's -1.14% of the current price https://t.co/FEEmgXgM66 January 12th 2020, 8:01pm |
|
@1MinuteStock Wondering about risks of $ALNY? The 21-day volatility is 6.87% https://t.co/cMORUQlfBZ January 12th 2020, 8:01pm |
 |
@TheUnicornBay Unicorn Bay rating for $ALNY is 1.46 out of 5. https://t.co/I98eHgWbA9 January 12th 2020, 8:01pm |
 |
@Miljenkoz RT @odibro: $ALNY Preliminary 4Q & Full Year 2019 Global Net Product Revenues and Provides Additional Commercial Updates #JPM20 https://t.c… January 12th 2020, 7:01pm |
|
@1MinuteStock Do you know that #WallStreet price for $ALNY is $134.65 https://t.co/NEnY4yrlCW January 12th 2020, 7:01pm |
 |
@StckPro $ALNY NEW ARTICLE : Alnylam announces preliminary 2019 results https://t.co/bX6w9Cwvm8 Get all the latest $ALNY rel… https://t.co/751BXOXtlR January 12th 2020, 6:01pm |
 |
@portefeuillefun $ALNY. #Alnylam Announces Preliminary Fourth Quarter and Full Year 2019 Global Net Product Revenues and Provides Ad… https://t.co/icZooIyrgU January 12th 2020, 6:01pm |
 |
@otcdynamics $ALNY Alnylam Announces Preliminary* Fourth Quarter and Full Year 2019 Global Net Product Revenues and Provides https://t.co/DFFdM1RUKD January 12th 2020, 6:01pm |
 |
@ChartMill $ALNY: Both the short term and long term trends are positive. This is a very positive sign. https://t.co/ExFnsXUDEQ https://t.co/c4dFDMIYQe January 12th 2020, 6:01pm |
 |
@odibro $ALNY Preliminary 4Q & Full Year 2019 Global Net Product Revenues and Provides Additional Commercial Updates #JPM20 https://t.co/psC6aO0KZX January 12th 2020, 6:01pm |
 |
@MarketChmln $ALNY upcoming event January 13: 38th Annual J.P. Morgan Healthcare Conference. Options expiring on January 17 that… https://t.co/FUyE6ZjZvl January 11th 2020, 11:01pm |
|
@dakotafinancial Alnylam Pharmaceuticals $ALNY Stock Price Passes Above 200 Day Moving Average of $90.05 https://t.co/VvcskiGUg9 January 10th 2020, 9:01pm |
 |
@WeekHerald Alnylam Pharmaceuticals $ALNY Share Price Crosses Above 200-Day Moving Average of $90.05 https://t.co/bIqzdSoYFc January 10th 2020, 9:01pm |
 |
@Briefingcom $ALNY: Alnylam Pharma initiates rolling submission of NDA to the FDA for lumasiran for the treatment of PH1 https://t.co/w0UgagYHOu January 10th 2020, 6:01pm |
|
@newsfilterio Alnylam launches U.S. application for lumasiran for PH1 $ALNY https://t.co/Pliz3Jwagt January 10th 2020, 5:01pm |
|
@MaisaCorp $ALNY seeking approval of a so-called RNAi drug to treat a rare inherited liver disorder that often results in prog… https://t.co/Egs6Uw3WvQ January 10th 2020, 4:01pm |
 |
@BioBonanos RT @jeff_cranmer: $ALNY takes next step toward meeting goal of having 4 approved drugs by YE 20, starts rolling BLA for lumasiran to treat… January 10th 2020, 4:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.